Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are ...

New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...

The bone-marrow needle is ... result of a very thickly packed marrow, which resisted aspiration. Two cases in this series demonstrate the value of using multiple sites for confirmation of the ...

A successful transplant gives someone with multiple myeloma new, healthy bone marrow. It replaces the bone marrow harmed by myeloma cells. Hematopoietic (hee-MA-toh-poy-EH-tik) stem cells (usually ...

lymphoproliferative disorders such as multiple myeloma, secondary neoplasia and infectious agents, as well as to determine staging of malignant neoplasia 1,2. Bone marrow aspiration is generally a ...

A team of researchers from the Translational Oncology Research Centre (TORC) of Vrije Universiteit Brussel (VUB), in collaboration with leading German universities, has developed a new biomaterial ...

July 1, 2024 — Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. It is considered incurable. Even when patients respond to treatment at first ...

Multiple myeloma and AL amyloidosis are conditions linked to plasma cells in the bone marrow. Multiple myeloma (MM) is a cancer affecting the plasma cells, which are mostly in the bone marrow.

Myeloma, or multiple myeloma, is a cancer affecting ... by the accumulation of abnormal plasma cells in the bone marrow, which impairs the normal production of blood cells. Recent results from ...

Multiple myeloma is a rare type of cancer. It starts with the uncontrolled production of plasma cells. These are a type of white blood cell in the bone marrow. Healthy plasma cells make antibodies ...